Evidence map›Paper›PMID 30782043›Full record

ArticleInnate immunity2019

Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin.

Young Suk Lee, Eduardo Davila, Tianshu Zhang, Hugh P Milmoe, Stefanie N Vogel, Jonathan S Bromberg, Joseph R Scalea

Open access · goldAbstract read
In one paragraph

Article in Innate immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Adjuvant conditioning induces an immunosuppressive milieu that delays alloislet rejection through the expansion of myeloid-derived suppressor cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  7. The Voltage-Gated Hv1 HInternational journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Young Suk Lee1 Department of Surgery, University of Maryland, Baltimore, USA.
Eduardo Davila2 Department of Microbiology and Immunology, University of Maryland, Baltimore, USA.
Tianshu Zhang1 Department of Surgery, University of Maryland, Baltimore, USA.
Hugh P Milmoe1 Department of Surgery, University of Maryland, Baltimore, USA.
Stefanie N Vogel2 Department of Microbiology and Immunology, University of Maryland, Baltimore, USA.
Jonathan S Bromberg1 Department of Surgery, University of Maryland, Baltimore, USA.
Joseph R Scalea1 Department of Surgery, University of Maryland, Baltimore, USA.
University of Maryland, Baltimore · US

Funding

Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung InjuryR01AI125215 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANCO, JORGE C, VOGEL, STEFANIE N. · 2017 to 2021
$2.7M
Macrophage differentiation and disease outcome in influenza infectionR01AI123371 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2017 to 2021
$2.7M
NIAID NIH HHS R01 AI123371
6 · The paper itself

Abstract

Myeloid-derived suppressor cells (MDSCs) inhibit T cell responses and are relevant to cancer, autoimmunity and transplant biology. Anti-thymocyte globulin (ATG) is a commonly used T cell depletion agent, yet the effect of ATG on MDSCs has not been investigated. MDSCs were generated in Lewis Lung Carcinoma 1 tumor-bearing mice. MDSC development and function were assessed in vivo and in vitro with and without ATG administration. T cell suppression assays, RT-PCR, flow cytometry and arginase activity assays were used to assess MDSC phenotype and function. MDSCs increased dramatically in tumor-bearing mice and the majority of splenic MDSCs were of the polymorphonuclear subset. MDSCs potently suppressed T cell proliferation. ATG-treated mice developed 50% fewer MDSCs and these MDSCs were significantly less suppressive of T cell proliferation. In vitro, ATG directly bound 99.6% of MDSCs. CCR7, L-selectin and LFA-1 were expressed by both T cells and MDSCs, and binding of LFA-1 was inhibited by ATG pre-treatment. Arg-1 and PD-L1 transcript expression were reduced 30-40% and arginase activity decreased in ATG-pretreated MDSCs. MDSCs were bound and functionally inhibited by ATG. T cells and MDSCs expressed common Ags which were also targets of ATG. ATG may be helpful in tumor models seeking to suppress MDSCs. Alternatively, ATG may inadvertently inhibit important T cell regulatory events in autoimmunity and transplantation.

Indexed as

AnimalsAntilymphocyte SerumB7-H1 AntigenCarcinoma, Lewis LungCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell ProliferationCells, CulturedDown-RegulationImmunosuppression TherapyL-SelectinLymphocyte ActivationMiceMice, Inbred C57BLMyeloid-Derived Suppressor CellsReceptors, CCR7Antilymphocyte SerumB7-H1 AntigenCcr7 protein, mouseL-SelectinReceptors, CCR7Antithymocyte globulinmyeloid derived suppressor cellstransplantation toleranceTransplant immunologyTregs

Identifiers

PMID30782043
PMCPMC6830891
OpenAlexW2908689765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.